Plant diseases cost Australia millions of dollars each year as they reduce productivity, increase the cost of production, impact on our ability to trade both locally and internationally and adversely affect our environment and biodiversity.
There are currently 225 plant genomes, of an estimated 403,000 genomes available. By unlocking genomic data we can significantly improve conservation management.
A catalyst program whereby cardiovascular researchers are partnering with the Bioplatforms network to develop and analyse ‘omics data in support of national collaborative research grants.
This initiative will directly support a number of conservation efforts and provide an infrastructure in the form of data and analytical pipelines to support biodiversity conservation in the hands of species management teams
Bioplatforms is committed to supporting the Australian life sciences community through a diverse access program, provision of targeted infrastructure requirements, and making integrated capability available to initiatives of breadth, scale and complexity in a way that is not readily achievable through other mechanisms.
Health and medical researchers investigate solutions to complex problems that are often not easily solved by a single discipline. The NCRIS Health Group is aimed at enabling them collaboratively throughout the innovation and translational process.
Bioplatforms Australia welcomes the recent announcement of the $185 million investment to fast-track treatments for rare and ‘untreatable’ cancers.
Bioplatforms Australia is seeking innovative ideas from current and potential future partners to identify opportunities to deepen and enhance the overall capability and capacity of its network.